Abstract
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline, an inhibitor of protozoan growth, presents an opportunity to explore nanostructured drug carriers to overcome these challenges. By encapsulating this compound in nanocarriers such as liposomes, dendrimers or polymeric nanoparticles, you can improve its solubility and protect it from degradation, thereby increasing circulation time and accumulation at the target site. This review will explore various nanostructured carriers for 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline, analyze their properties, and discuss how nanotechnology can enhance the efficacy of this antiparasitic agent. With the prevalence of parasitic diseases around the globe nanomedicine may provide the solution by enabling more effective delivery of compounds like 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
